INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.

Getting diagnosed with Alzheimer's disease affects one's life expectancy. However, there are various factors that can ...

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

Working for the Alzheimer’s Association, Beth Sulkowski has heard the same story many times over the years: People who ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.

The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs targeting diseases of the central nervous system (CNS). Because of this barrier there is a huge ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

2-Year U.S. Treasury Note Continuous Contract $102.863 0.059 0.06% 5-Year U.S. Treasury Note Continuous Contract $106.461 0.156 0.15% 10-Year U.S. Treasury Note Continuous Contract $108.969 0.219 ...